SRT Sartorius AG

EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret

EQS-News: SARTORIUS AG / Key word(s): Personnel
Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret (news with additional features)

02.07.2024 / 10:53 CET/CEST
The issuer is solely responsible for the content of this announcement.


 

Göttingen, July 2, 2024

Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret

The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that after more than 20 years as CEO of the company, he will not be seeking another extension of his current contract when it expires in November 2025. The Supervisory Board has taken note of Kreuzburg's decision with great regret.

Kreuzburg has been at the helm of the company since 2003. After joining Sartorius AG in 1999, he was appointed to the Executive Board in 2002 at the age of 37 and became Chairman a few months later. During this time, Sartorius’ sales revenue increased more than 7-fold to around 3.4 billion euros and profits more than 26-fold to around 1 billion euros, the number of employees quadrupled to over 14,000 while the Group's stock market valuation increased from just over 90 million euros to more than 17 billion euros.

The Chairman of the Supervisory Board of Sartorius AG, Dr. Lothar Kappich, said: “Sartorius owes Joachim Kreuzburg an extraordinary amount. With his dynamic entrepreneurial qualities, he has transformed the company into an internationally leading and particularly profitable life science group, expanded the technology and product portfolio enormously and built up an outstanding team. We very much regret his decision. At the same time, we would like to thank him for informing us of his decision at an early stage and for continuing to be available to Sartorius until November 2025. The Supervisory Board will now initiate a succession process in an orderly and careful manner. I look forward to continuing to work so closely and well with Joachim Kreuzburg for another one and a half years until his departure.”

Kreuzburg said: “After so many years at the helm of this special company, I would like to have more space and time for new topics and projects in the future. For the upcoming phase of my life, I am ruling out taking on an executive top role, while I will continue to be involved in my mandates in business and science and will also engage in further business activities, especially in such innovation-driven sectors as biotechnology and medicine. After a phase of extraordinary growth, the entire life science industry is facing temporary challenges in the current "post-pandemic phase", while the prospects for the future remain excellent. The trough has been passed and I will continue to fully focus on Sartorius over the next year and a half and, together with my team, will work with all my energy to ensure that the company continues to develop more innovatively, faster and more profitably than the competition. At the same time, it was important to me to inform the Supervisory Board of my plans at an early point so that they can prepare for my succession without time pressure.”



A profile of Sartorius
Sartorius (XETRA: SRT3 | STR) is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. The company, based in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide. Sartorius regularly expands its portfolio through the acquisition of complementary technologies. In 2023, the company generated sales revenue of around 3.4 billion euros. Currently, around 14,600 employees are working for customers around the globe.

Visit our and follow Sartorius on .

Contact
Petra Kirchhoff
Head of Corporate Communications & Investor Relations
+49 (0)551.308.1686


 

Additional features:

File:


02.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: SARTORIUS AG
Otto-Brenner-Straße 20
37079 Göttingen
Germany
Phone: +49.(0)551-308.0
Fax: +49.(0)551-308.3289
E-mail:
Internet:
ISIN: DE0007165607, DE0007165631
WKN: 716560 , 716563
Indices: DAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1937941

 
End of News EQS News Service

1937941  02.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1937941&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
02/07/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sartorius AG

Sartorius: 1 director

A director at Sartorius bought 400 shares at 173.350EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

Thomas J. Schiessle
  • Thomas J. Schiessle

CEO verlängert nicht über Nov. 2025 hinaus - Q1/24 dokumentierte opera...

Nach knapp 20 Jahren als hat CEO Dr. Joachim Kreuzburg angekündigt – aus Gründen der persönlichen Lebensplanung - keine nochmalige Vertrags­verlängerung - über den 30.11.25 hinaus – anzustreben; er strebe ferner keine operative Position in einem anderen Unternehmen an. Die Ankeraktionäre werden nun wichtig: Seit in 2023 ist Bio-Rad Laboratories Inc. Aktionär (derzeit Anteil an  Ord. 28%; Pref: 38%). Durch Lothar Kappich (SRT-AR-Vorsitz) wird die Horst Sartorius Erbengemeinschaft in Höhe von 50,0...

Thomas J. Schiessle
  • Thomas J. Schiessle

CEO will not extend beyond Nov. 2025 - Q1/24 documented operational tu...

After almost 20 years as CEO, Dr Joachim Kreuzburg has announced - for reasons of personal life planning - that he will not seek a further contract extension beyond 30.11.2025; furthermore, he will not seek an operational position in another company. The anchor shareholders are now becoming important: Bio-Rad Laboratories Inc. has been a shareholder since 2023 (current share in Ord. 28%; Pref: 38%). Lothar Kappich (SRT-SB-Chairman) represents the Horst Sartorius community of heirs in the amount ...

 PRESS RELEASE

EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuz...

EQS-News: SARTORIUS AG / Key word(s): Personnel Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret (news with additional features) 02.07.2024 / 10:53 CET/CEST The issuer is solely responsible for the content of this announcement.   Göttingen, July 2, 2024 Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the ...

 PRESS RELEASE

EQS-News: Sartorius AG: Joachim Kreuzburg strebt nach mehr als 20 Jahr...

EQS-News: SARTORIUS AG / Schlagwort(e): Personalie Sartorius AG: Joachim Kreuzburg strebt nach mehr als 20 Jahren als Vorstandsvorsitzender keine weitere Amtszeit an – Aufsichtsrat äußert großes Bedauern (News mit Zusatzmaterial) 02.07.2024 / 10:53 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Göttingen, 2. Juli 2024 Sartorius AG: Joachim Kreuzburg strebt nach mehr als 20 Jahren als Vorstandsvorsitzender keine weitere Amtszeit an – Aufsichtsrat äußert großes Bedauern Der langjährige Vorstandsvorsitzende der Sartorius AG, Dr. Joachim ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch